Circulating DNA and next-generation sequencing

Recent Results in Cancer Research

Volumn 195, Issue , 2012, Pages 143-149

  Cooke, Susanna ^a   Campbell, Peter ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER GENETICS; CIRCULATING TUMOR CELL; DISEASE ASSOCIATION; DNA DEGRADATION; DNA DETERMINATION; DNA METHYLATION; DNA SEQUENCE; GENE MUTATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; HUMAN; MOLECULAR DIAGNOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOLID TUMOR;

DNA; HUMANS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84860588781     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-28160-0_12     Document Type: Article

References (22)

1. Branford S (2007) Chronic myeloid leukemia: molecular monitoring in clinical practice. Am Soc Hematol Educ Program 2007:376
2. Mandel P, Metais P (1948) Les acides nucleiques du plasma sanguin chez l0homme. CR Acad Sci Paris 142:241
3. Steinman CR (1975) Free DNA in serum and plasma from normal adults. J Clin Invest 56:512
4. Stroun M, Lyautey J, Lederrey C et al (2001) About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clinica chimica acta; J Clin Chem 313:139
5. Choi JJ, Reich CF 3rd, Pisetsky DS (2005) The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology 115:55
6. Jahr S, Hentze H, Englisch S et al (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61:1659
7. Diehl F, Li M, Dressman D et al (2005) Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci USA 102:16368
8. Leon SA, Shapiro B, Sklaroff DM et al (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37:646
9. Fournie GJ, Courtin JP, Laval F et al (1995) Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 91:221
10. Diehl F, Schmidt K, Choti MA et al (2008) Circulating mutant DNA to assess tumor dynamics. Nat Med 14:985
11. Sorenson GD, Pribish DM, Valone FH et al (1994) Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomark Prev 3:67
12. Leary RJ, Kinde I, Diehl F et al (2010) Development of personalized tumor biomarkers using massively parallel sequencing. Sci Transl Med 2:20ra14
13. Esteller M, Sanchez-Cespedes M, Rosell R et al (1999) Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA fromnon-small cell lung cancer patients. Cancer Res 59:67
14. Wong IH, Lo YM, Zhang J et al (1999) Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 59:71
15. Grutzmann R, Molnar B, Pilarsky C et al (2008) Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PloS One 3:e3759
16. Margulies M, Egholm M, Altman WE et al (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature 437:376
17. Bentley DR, Balasubramanian S, Swerdlow HP et al (2008) Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456:53
18. McKernan KJ, Peckham HE, Costa GL et al (2009) Sequence and structural variation in a human genome uncovered by short-read, massively parallelligation sequencing using two-base encoding. Genome Res 19:1527
19. Campbell PJ, Stephens PJ, Pleasance ED et al (2008) Identification of somatically acquired rearrangements in cancer using genome-wide massivelyparallel paired-end sequencing. Nat Genet 40:722
20. McBrid DJ, Orpana AK, Sotiriou C et al (2010) Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors. Genes Chromosom Cancer 49:1062
21. Umetani N, Giuliano AE, Hiramatsu SH et al (2006) Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol 24:4270
22. Wang M, Block TM, Steel L et al (2004) Preferential isolation of fragmented DNA enhances the detection of circulating mutated k-ras DNA. Clin Chem 50:211